Author
Listed:
- Kristen A. Baltgalvis
(Vividion Therapeutics)
- Kelsey N. Lamb
(Vividion Therapeutics)
- Kent T. Symons
(Vividion Therapeutics)
- Chu-Chiao Wu
(Vividion Therapeutics)
- Melissa A. Hoffman
(Vividion Therapeutics)
- Aaron N. Snead
(Vividion Therapeutics)
- Xiaodan Song
(Vividion Therapeutics)
- Thomas Glaza
(Vividion Therapeutics)
- Shota Kikuchi
(Vividion Therapeutics)
- Jason C. Green
(Vividion Therapeutics)
- Donald C. Rogness
(Vividion Therapeutics)
- Betty Lam
(Vividion Therapeutics)
- Maria E. Rodriguez-Aguirre
(Vividion Therapeutics)
- David R. Woody
(Vividion Therapeutics)
- Christie L. Eissler
(Vividion Therapeutics)
- Socorro Rodiles
(Vividion Therapeutics)
- Seth M. Negron
(Vividion Therapeutics)
- Steffen M. Bernard
(Vividion Therapeutics)
- Eileen Tran
(Vividion Therapeutics)
- Jonathan Pollock
(Vividion Therapeutics)
- Ali Tabatabaei
(Vividion Therapeutics)
- Victor Contreras
(Vividion Therapeutics)
- Heather N. Williams
(Vividion Therapeutics)
- Martha K. Pastuszka
(Vividion Therapeutics)
- John J. Sigler
(Vividion Therapeutics)
- Piergiorgio Pettazzoni
(Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd)
- Markus G. Rudolph
(Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd)
- Moritz Classen
(Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd)
- Doris Brugger
(Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd)
- Christopher Claiborne
(Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd)
- Jean-Marc Plancher
(Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd)
- Isabel Cuartas
(CIBERONC)
- Joan Seoane
(CIBERONC)
- Laurence E. Burgess
(Vividion Therapeutics)
- Robert T. Abraham
(Vividion Therapeutics
Odyssey Therapeutics)
- David S. Weinstein
(Vividion Therapeutics)
- Gabriel M. Simon
(Vividion Therapeutics)
- Matthew P. Patricelli
(Vividion Therapeutics)
- Todd M. Kinsella
(Vividion Therapeutics)
Abstract
No abstract is available for this item.
Suggested Citation
Kristen A. Baltgalvis & Kelsey N. Lamb & Kent T. Symons & Chu-Chiao Wu & Melissa A. Hoffman & Aaron N. Snead & Xiaodan Song & Thomas Glaza & Shota Kikuchi & Jason C. Green & Donald C. Rogness & Betty , 2024.
"Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase,"
Nature, Nature, vol. 631(8021), pages 12-12, July.
Handle:
RePEc:nat:nature:v:631:y:2024:i:8021:d:10.1038_s41586-024-07595-7
DOI: 10.1038/s41586-024-07595-7
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:631:y:2024:i:8021:d:10.1038_s41586-024-07595-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.